MedPage Today on MSN2d
Varipulse Returns; HCM Genes Reconsidered; Early Blood Test for Preeclampsia?
To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...
News Medical on MSN6d
A step toward precision medicine: New drug targets for heart failure
A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...
Medscape10d
Gait Speed Better Predicts Heart Failure Outcomes Than Muscle Mass or Strength
Slower gait speed, but not handgrip strength or muscle mass, is associated with an increased risk for cardiovascular outcomes ...
Medscape7d
Shunt System Still Improving HF Symptoms at 2 Years
A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...
News Medical on MSN8d
National study underway to test new mechanical heart pump
A national clinical trial is underway to compare a novel mechanical heart pump to the only device currently used to treat end-stage heart failure. The INNOVATE study, led by University of Michigan, wi ...
The American Journal of Managed Care13d
Ifetroban Improves Heart Function in DMD
There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
Daily11d
Oral finerenone may reduce risk of new-onset diabetes in heart failure patients: Lancet
A recent study from the FINEARTS-HF trial revealed that finerenone, which is an oral mineralocorticoid receptor antagonist, ...
Pharmabiz5d
Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure
Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...